Immunome Inc. - 10-Q Filing
Immunome Inc. filed its Q1 2026 10-Q report showing a net loss of $53,839 thousand compared to $41,640 thousand in the same period last year. The company reported no collaboration revenue for the quarter ended March 31, 2026, down from $2,926 thousand in Q1 2025.
Tickers: $IMNM